SCYNEXIS, Inc. Reports Third Quarter 2015 Financial Results and Provides Company Update

Nov 13, 2015

SCYNEXIS, Inc. Announces Initiation of Phase 1 Clinical Trial Evaluating Intravenous Formulation of SCY-078

Nov 12, 2015

SCYNEXIS Appoints Eric Francois as Chief Financial Officer

Nov 2, 2015

SCYNEXIS Appoints Rajeshwar Motheram as Vice President, Pharmaceutical Development

Oct 7, 2015

SCYNEXIS, Inc. Announces Board of Directors Transitions

Sep 28, 2015

SCYNEXIS Presents Data Supporting the Potential Clinical Utility of Antifungal Drug Candidate at ICAAC/ICC 2015

Sep 21, 2015

SCYNEXIS to Present Data at ICAAC/ICC 2015 for Novel Antifungal Drug Candidate

Sep 10, 2015

SCYNEXIS, Inc. Reports Second Quarter 2015 Financial Results

Aug 19, 2015

SCYNEXIS, Inc. to Present at 35th Canaccord Genuity Annual Growth Conference

Aug 10, 2015

SCYNEXIS, Inc. to Focus on SCY-078 Development

Jul 23, 2015